News

• December 30, 2009

  CorAssist Successfully Demonstrates CORolla TM Transapical Delivery & Positioning at the LTCS Live Implantation Demonstration Brings CORolla TM One Step Closer to the Clinic
  Read more...




• March 12, 2009

  CorAssist Raises $5.25 Million In Private Financing
  Read more...




• September 14, 2008

  CorAssist Proves Efficacy In Animals And Shows 6 Months Safety In Humans
  Read more...




• September 2008

  CorAssist is proud to announce that we were nominated as a runner-up for this year’s Techno-College Innovation Award by The EACTS New Technology Committee.
  The Award presentation will take place during the opening session of this year’s Techno- College in Lisbon, Portugal on Saturday, September 13 at the 22nd EACTS Annual Meeting.
  Mr. Volkmar Falk Chair, EACTS new Technology Committee will highlight the top three innovations.




• August 2008

  Successful 3 month follow up on first 2 patients implanted with the ImCardia™.




• May 2008

  The ImCardia™ Implantation procedure FIM was presented at the WCSTS PCR and Biomed 2008 conferences.




• April 2008

  CorAssist is proud to announce FIM (First in Man) implantation in two patients. For the first time an innovative device-based solution has been implanted in human as part of the ImCardia™ for DHF – Safety and Functionality multicenter Pilot study. First follow up results are expected at the End of June 2008.




• March 2008

  Efficacy in diseased animal demonstrates that in animal model in which hypertrophy was induced, 2D strain analysis revealed device related global and local diastolic improvement compared to control group.




• December 2007

  CorAssist completed Pre-IDE meeting with the FDA in which the general path of ImCardia™ preclinical plan (in vivo and bench tests) and clinical plan was discussed and agreed. The meeting paved the way to initiation of the ImCardia ™ clinical study.




• November 2007

  CorAssist has completed preliminary proof of concept for the ImCardia™ MIS, the second generation of its first product, the ImCardia™, which enables implantation of the device through a small incision.




• August 2007

  CorAssist is proud to announce that it has obtained ISO certification (ISO 13485:2003) for its Quality Management System. ISO certification will allow the company to begin ImCardia™ manufacturing for clinical trials.
  CorAssist has completed preliminary proof of concept for its second product, the CORolla™, a new intraventricular device for diastolic heart failure.